5-HT4 receptor antagonism in irritable bowel syndrome: Effect of SB-207266-A on rectal sensitivity and small bowel transit

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 11, 1999, Pages 1437-1444

  Houghton, L A ^a   Jackson, N A ^a   Whorwell, P J ^a   Cooper, S M ^b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 BUTYL 4 PIPERIDINYLMETHYL 3,4 DIHYDRO 2H [1,3]OXAZINO[3,2 A]INDOLE 10 CARBOXAMIDE; PIBOSEROD; SEROTONIN 4 ANTAGONIST; UNCLASSIFIED DRUG; INDOLE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DIARRHEA; FATIGUE; FEMALE; HEADACHE; HUMAN; INTESTINE TRANSIT TIME; IRRITABLE COLON; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; UPPER RESPIRATORY TRACT INFECTION; BALLOON DILATATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GASTROINTESTINAL TRANSIT; MANOMETRY; MIDDLE AGED; RECTUM; SMALL INTESTINE;

ADULT; AGED; BALLOON DILATATION; COLONIC DISEASES, FUNCTIONAL; CROSS-OVER STUDIES; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; INDOLES; INTESTINE, SMALL; MALE; MANOMETRY; MIDDLE AGED; PIPERIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; RECTUM; SEROTONIN ANTAGONISTS;

EID: 0032589965     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00625.x     Document Type: Article

References (32)

1. 1 Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14: 125-32.
2. 2 Prior A, Sorial E, Sun WM, Read NW. Irritable bowel syndrome: difference between patients who show rectal sensitivity and those who do not. Eur J Gastroenterol Hepatol 1993; 5: 343-9.
3. 3 Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin US, Schuster MM. Tolerance for rectosigmoid distension in irritable bowel syndrome. Gastroenterology 1990; 98: 1187-92.
4. 4 Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
5. 5 Mayer EA, Munakata J, Mertz H, Lembo T, Bernstein CN. Visceral hyperalgesia and irritable bowel syndrome. In: Gebhert GF, ed. Visceral Pain, Progress in Pain Research and Management, Vol. 5. Seattle: IASP Press. 429-68.
6. 6 Timble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceral sensation in functional gastrointestinal disease is not site specific. Evidence for a generalised disorder of gut sensitivity. Dig Dis Sci 1995; 40: 1607-13.
7. 7 Francis CY, Houghton LA, Whorwell PJ, Morris J. Enhanced sensitivity of the whole gut in patients with irritable bowel syndrome. Gastroenterology 1995; 108: A60J (Abstract).
8. 8 Sanger GJ. Hypersensitivity and hyperreactivity in the irritable bowel syndrome: an opportunity for drug discovery. Dig Dis Sci 1999, in press.
9. 9 Sanger GJ. 5-Hydroxytryptamine and functional bowel disorders. Neurogastroenterol Motil 1996; 8: 319-31.
10. 4 receptor antagonism by SB-207266. Br J Pharmacol 1996; 118: 665-70.
11. 11 Nagakura Y, Kamato T, Nishida A, Ito H, Yamano M, Miuyata K, Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Naunyn-Schmiedebergs Arch Pharmacol 1996; 353: 489-98.
12. 4 receptors arc not involved in the control of small intestinal transit in the fasted, conscious rat. Neurogastroenterol Motil 1996; 8: 1-8.
13. 4 receptors in the 5-hydroxytryptamine-induced pattern of migrating myoelectric complex in sheep. Br J Pharmacol 1997; 120: 1144-50.
14. 4 receptor activation in the mouse. Eur J Pharmacol 1996; 308: 181-6.
15. 15 Hedge SS, Moy TM, Perry MR, Loeb M, Eglen RM. Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptamine-indueed diarrhea in mice. J Pharmacol Exp Ther 1994; 271: 741-7.
16. 4 receptor activation. Br J Pharmacol 1991; 102: 563-4.
17. 4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum. Br J Pharmacol 1993; 110: 1572-8.
18. 4 receptor antagonist affinities of SB-207710, SB-205008 and SB-203186 in the human colon, rat oesophagus and guinea-pig ileum peristaltic reflex, Naunyn-Schmiedeberg's Arch Pharmacol 1995; 352: 132-40.
19. 4 receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitisation of peristalsis and increased defaecation in animal models, Neurogastroenterol Motil 1998; 10: 271-9.
20. 4 receptors in ascending and descending reflexes to the circular muscle of guinea-pig small intestine, Br J Pharmacol 1994; 112: 1095-100.
21. 4) receptor antagonist on gastrointestinal (GI) transit, colonic motor and sensory function in health. Gastroenterology 1999; 16: G4170 (Abstract).
22. 22 Moore BA, Sharkey KA, Mantle M. Role of 5-HT in cholera toxin-induced mucin secretion in the rat small intestine. Am J Physiol 1996; 270: G1001-9.
23. 4 receptor. Am J Physiol 1994; 267: G357-63.
24. 4 receptor function. J Pharm Pharmacol 1995; 47: 219-22.
25. 4 antagonists of stress-induced colonic dysfunction and visceral pain in the rat. Gastroenterology 1996; 110: A735 (Abstract).
26. 4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons. J Neurosci 1997; 17: 7181-9.
27. 27 Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992; 5: 75-91.
28. 28 Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med 1969; 28: 122-7.
29. 29 Bearcroft CP, Perrett D, Farthing MJG. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42-6.
30. 4 receptor antagonists. Exp Opin Ther Patents 1994; 4: 1.
31. 4 receptor. Med Res Rev 1993; 13: 633-62.
32. 32 Van Zanten S, Talley N, Whorwell PJ. et al. Design of treatment trials on functional gastrointestinal disorders. Gut (Suppl.) 1999, in press.